miscarriage%20-%20spontaneous
MISCARRIAGE - SPONTANEOUS

Spontaneous miscarriage is the loss of fetus before 20 weeks of gestation or delivery of a fetus weighing <500 g, in the absence of elective medical or surgical measures to terminate pregnancy.
Early loss is considered if it occurred before menstrual week 12 while late loss refers to those that occurred from menstrual week 12-20.
It is also known as spontaneous abortion, spontaneous pregnancy loss or early pregnancy failure.

Miscarriage%20-%20spontaneous Management

Follow Up

After Expectant Management
  • In patients with pregnancy of <6 weeks who had bleeding but no pain, repeat urine pregnancy test after 7-10 days and return for follow-up if positive
    • Negative pregnancy test means that pregnancy has miscarried
  • In patients who completed miscarriage during 7-14 days of expectant management, repeat urine pregnancy test after 3 weeks and to return if it showed a positive result
  • If bleeding and pain have started and are persisting or worsening, repeat scan after the expectant management period and offer other treatment options (eg continued expectant management, medical management, surgical management)
  • In patients who continued the expectant management, review the condition of the patient again 14 days after the first follow-up appointment
After Medical Management
  • Advise patient to return for check up 24 hours after treatment has been given if bleeding has not started
  • If there are no worsening symptoms after medical management, urine pregnancy test should be done after 3 weeks
    • Molar or ectopic pregnancy should be ruled out if the test turned out positive
Contraception
  • Hormonal contraception and barrier methods may be started immediately following completion of early pregnancy loss
  • An intrauterine device may be used if there is no suspicion of septic miscarriage

Counselling

Genetic Counselling
  • Offers a prognosis for the risk of future pregnancies with an unbalanced chromosome complement and the opportunity for familial chromosome studies
  • Should be done in patients with recurrent pregnancy loss secondary to structural genetic factor
    • Subsequent healthy live birth depends on the involved chromosomes and rearrangement type
    • Treatment options for partners with recurrent pregnancy loss and a structural genetic abnormality include preimplantation genetic diagnosis for specific translocations, with transfer of unaffected embryos, or the use of donor gametes; however, more evidences are needed to demonstrate that In Vitro Fertilization (IVF)/preimplantation genetic diagnosis improves live birth rate compared to natural conception/medical management
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Jairia Dela Cruz, 5 days ago
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.
5 days ago
Use of thyroid hormone therapy does not seem to protect older adults with subclinical hypothyroidism against mortality, but it appears to confer survival benefits to those aged <65 years, results of a study have shown.